Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.30 is 23% above its 1-year average of 6.77, near the high end of its 1-year range (2.85–9.17).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.30.
CURRENT RATIO
8.30
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
+138.59%
vs the sector median at left
Market Cap
$1.82B
Current Ratio
16.31
TTM Avg
13.02
3Y Avg
9.73
5Y Avg
8.18
Market Cap
$1.73B
Current Ratio
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.86B
Current Ratio
21.18
TTM Avg
6.27
3Y Avg
4.65
5Y Avg
4.09
Market Cap
$1.73B
Current Ratio
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.79B | 8.30 | N/A | N/A | N/A |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 16.31 | 13.02 | 9.73 | 8.18 |
| Novocure Ltd (NVCR)vs › | $1.83B | 2.89 | 2.18 | 4.29 | 5.58 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | 6.65 | 5.42 | 7.28 | 7.47 |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 1.23 | 1.57 | 2.04 | 2.44 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | 21.18 | 6.27 | 4.65 | 4.09 |
| Absci Corporation (ABSI)vs › | $1.84B | 10.63 | 5.62 | 5.37 | 6.14 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.73B | 1.70 | 1.79 | 1.95 | 2.14 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | 1.63 | 1.31 | 1.40 | 1.40 |
| Personalis, Inc. (PSNL)vs › | $1.71B | 5.28 | 6.64 | 5.61 | 6.33 |
Current Ratio
8.30
Quick Ratio
8.30
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.30 |
| 2026-03-31 | 9.17 |
| 2025-12-31 | 2.85 |
